Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A candidate molecular signature associated with tamoxifen failure in primary breast cancer

17 Oct 2008

Abstract excerpt

INTRODUCTION: Few markers are available that can predict response to tamoxifen treatment in estrogen receptor (ER)-positive breast cancers. Identification of such markers would be clinically useful. We attempted to identify molecular markers associated with tamoxifen failure in breast cancer. METHODS: Eighteen initially ER-positive patients treated with tamoxifen requiring salvage surgery (tamoxifen failure [TF]...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Cancer Treatment Studies
Share to Estrogen and related hormone effects
Share to HER2/EGFR in Cancer Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18928543
DOI: 10.1186/bcr2158

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A candidate molecular signature associated with tamoxifen failure in primary breast cancerPMID 18928543Read ↗

Gene Expression Profiles for Recurrence of Lymph Node-positive Primary Breast Cancer in Women Over 40 Years of AgeSemantic proximity Read ↗

Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.Semantic proximity Read ↗

Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast CancerSemantic proximity Read ↗

Identification of a Putative Protein Profile Associated with Tamoxifen Therapy Resistance in Breast CancerSemantic proximity Read ↗

Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer.Semantic proximity Read ↗

Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative breast cancer: An ad-hoc analysis of the JBCRG-C06 Safari studySemantic proximity Read ↗

Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer.Semantic proximity Read ↗

Gene Expression Profiles of Primary Breast Carcinomas from Patients at High Risk for Local Recurrence after Breast-Conserving TherapySemantic proximity Read ↗

Functional Screen for Genes Responsible for Tamoxifen Resistance in Human Breast Cancer CellsSemantic proximity Read ↗

Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype.Semantic proximity Read ↗

Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line.Semantic proximity Read ↗

ER, HER2, and TOP2A expression in primary tumor, synchronous axillary nodes, and asynchronous metastases in breast cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.